Ultime notizie per Implanet (OTC:IMPZY) Azioni

Implanet SA designs produce and sell medical implants and devices used in orthopedic surgery. Its products include prosthetic knees, spinal bracing systems, intersomatic cages, pins, suture threads, screws, and anchors. The company operates in a single segment - the commercialization of orthopedic implants. It derives most of its geographical revenue from France.

Implanet SA

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 400 points on Friday.
The Dow traded up 1% to 42,182.88 while the NASDAQ surged 1.18% to 18,309.37. The S&amp;P 500 also rose, gaining, 0.98% to 5,761.25.
Check This Out: <a href="https://www.benzinga.com/news/24/10/41653495/top-2-real-estate-stocks-you-may-want-to-dump-this-quarter">Top 2 Real Estate Stocks You May Want To Dump This Quarter</a>
Leading and Lagging Sectors Consumer discretionary shares rose by 3.1% on Friday.
In trading on Friday, utilities shares fell by 0.1%.
Top Headline
The U.S. economy added 12,000 jobs in October compared to a revised 223,000 gain in September and versus market estimates of 113,000.
Average hourly earnings increased by 0.4% over a month to $35.46 in October, while unemployment rate came in unchanged at 4.1% in October.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>ChromaDex Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDXC#NASDAQ">CDXC</a>) shares shot up 55% to $5.38 after the company reported a year-over-year increase in third-quarter EPS results and raised its FY24 revenue guidance.</li>
<li>Shares of Proto Labs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRLB#NASDAQ">PRLB</a>) got a boost, surging 33% to $36.54 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter adjusted EPS guidance with its midpoint above estimates.</li>
<li>Interface, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TILE#NASDAQ">TILE</a>) shares were also up, gaining 32% to $23.04 after the company reported better-than-expected third-quarter financial results and raised its FY24 net sales guidance above estimates.</li>
</ul>
Equities Trading DOWN
<ul>
<li>ESSA Pharma Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPIX#NASDAQ">EPIX</a>) shares dropped 70% to $1.5450 after the company announced it terminated its Phase 2 study evaluating masofaniten combined with enzalutamide in patients with mCRPC.</li>
<li>Shares of Elevai Labs Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELAB#NASDAQ">ELAB</a>) were down 45% to $0.0325.</li>
<li>Lexicon Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXRX#NASDAQ">LXRX</a>) was down, falling 34% to $1.2790. Lexicon Pharmaceuticals announced the outcome of the FDA's Endocrinologic and Metabolic Drugs Advisory Committee Meeting to review the company's New Drug Application (NDA) for Zynquista (sotagliflozin). The company is seeking approval for the oral SGLT1/SGLT2 inhibitor as an adjunct to insulin therapy for glycemic control in adults with type 1 diabetes (T1D) and chronic kidney disease (CKD).</li>
</ul>
Commodities In commodity news, oil traded up 1.5% to $70.39 while gold traded up 0.4% at $2,761.30.
Silver traded up 0.3% to $32.890 on Friday, while copper rose 0.4% to $4.3575.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 1%, Germany's DAX gained 0.8% and France's CAC 40 gained 0.7%. Spain's IBEX 35 Index surged 1.2%, while London's FTSE 100 rose 0.8%.
Asia Pacific Markets
Asian markets closed mostly lower on Friday, with Japan's Nikkei 225 falling 2.63%, Hong Kong's Hang Seng Index gaining 0.93%, China's Shanghai Composite Index declining 0.24% and India's BSE Sensex falling 0.27%.
Economics
<ul>
<li>The U.S. economy added 12,000 jobs in October compared to a revised 223,000 gain in September and versus market estimates of 113,000.</li>
<li>Average hourly earnings increased by 0.4% over a month to $35.46 in October, while unemployment rate came in unchanged at 4.1% in October.</li>
<li>U.S. construction spending increased by 0.1% month-over-month to an annual rate of $2,148.8 billion in September.</li>
<li>The S&amp;P Global Flash manufacturing PMI was revised upward to 48.5 in October versus a preliminary reading of 47.8.</li>
<li>The ISM manufacturing PMI declined to 46.5 in October versus 47.2 in the previous month and down from estimates of 47.6.</li>
</ul>
Now Read This: 
<ul>
<li><a href="Top%202%20Utilities%20Stocks%20That%20May%20Crash%20This%20Quarter">Top 2 Utilities Stocks That May Crash This Quarter</a></li>
</ul>

Earnings

Equities

News

Eurozone

Commodities

Markets

Trading Ideas

CDXC

ELAB

EPIX

LXRX

PRLB

TILE

Dow Jumps 400 Points; US Adds 12,000 Jobs In October

Scotiabank analyst Kevin Krishnaratne maintains Open Text (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTEX#NASDAQ">OTEX</a>) with a Sector Perform and lowers the price target from $40 to $35.

Price Target

Analyst Ratings

OTEX

Scotiabank Maintains Sector Perform on Open Text, Lowers Price Target to $35

Truist Securities analyst Tobey Sommer maintains Insperity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSP#NYSE">NSP</a>) with a Hold and lowers the price target from $95 to $88.

Truist Securities Maintains Hold on Insperity, Lowers Price Target to $88

Truist Securities analyst Nicole Germino reiterates Insmed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSM#NASDAQ">INSM</a>) with a Buy and raises the price target from $100 to $105.

Reiteration

INSM

Truist Securities Reiterates Buy on Insmed, Raises Price Target to $105

Options

Sunrun Option Alert: Nov 15 $16 Calls Sweep (50) Above Ask: 1572 @ $1.4 Vs 21838 OI; Earnings 11/7 After Close Ref=$14.7299

Benchmark analyst Mike Hickey maintains Roblox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) with a Buy and raises the price target from $44 to $60.

RBLX

Benchmark Maintains Buy on Roblox, Raises Price Target to $60

PLUG

Plug Power Option Alert: Fri $2 Calls Sweep (16) Near The Ask: 4494 @ $0.091 Vs 4726 OI; Earnings 11/15 After Close [est] Ref=$2.09

PLAY

Dave & Buster's Enter Option Alert: Apr 17 $45 Calls Sweep (10) Near The Ask: 1109 @ $3.632 Vs 861 OI; Earnings 12/3 After Close [est] Ref=$37.95

Truist Securities analyst Tobey Sommer maintains ICF International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICFI#NASDAQ">ICFI</a>) with a Hold and raises the price target from $155 to $180.

ICFI

Truist Securities Maintains Hold on ICF International, Raises Price Target to $180

Nexalin Technology, Inc. (the "Company" or "Nexalin") (NASDAQ:<a href="https://www.benzinga.com/stock/NXL#NASDAQ">NXL</a>, NXLIW)) announced that the Company received notice from The Nasdaq Stock Market ("Nasdaq") on October 31, 2024, notifying the Company that it has regained compliance with Nasdaq's minimum bid price requirement under Nasdaq Rule 5550(a)(2).

Nexalin Technology Regains Compliance With Nasdaq Continued Listing Requirements

Scotiabank analyst Andrew Weisel maintains Entergy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETR#NYSE">ETR</a>) with a Sector Perform and raises the price target from $119 to $144.

Scotiabank Maintains Sector Perform on Entergy, Raises Price Target to $144

Truist Securities analyst Patrick Scholes maintains Hyatt Hotels (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/H#NYSE">H</a>) with a Buy and lowers the price target from $169 to $158.

Truist Securities Maintains Buy on Hyatt Hotels, Lowers Price Target to $158

Benchmark analyst Mark Miller reiterates Onto Innovation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONTO#NYSE">ONTO</a>) with a Buy and maintains $230 price target.

ONTO

Benchmark Reiterates Buy on Onto Innovation, Maintains $230 Price Target

Truist Securities analyst Michael Swartz maintains Fox Factory Hldg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXF#NASDAQ">FOXF</a>) with a Buy and lowers the price target from $54 to $42.

FOXF

Truist Securities Maintains Buy on Fox Factory Hldg, Lowers Price Target to $42

Scotiabank analyst Francisco Suarez maintains Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) with a Sector Outperform and lowers the price target from $8.9 to $8.2.

Scotiabank Maintains Sector Outperform on Cemex, Lowers Price Target to $8.2

Benchmark analyst John Lawrence reiterates Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Buy and maintains $150 price target.

FRPT

Benchmark Reiterates Buy on Freshpet, Maintains $150 Price Target

Truist Securities analyst Jamie Cook maintains Fortive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTV#NYSE">FTV</a>) with a Buy and lowers the price target from $90 to $89.

Truist Securities Maintains Buy on Fortive, Lowers Price Target to $89

BACQU

Trading Halt: Halt status updated at 10:35:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

Scotiabank analyst Orest Wowkodaw maintains Champion Iron (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CIA#TSX">CIA</a>) with a Sector Perform and lowers the price target from C$6.75 to C$6.5.

TSX:CIA

Scotiabank Maintains Sector Perform on Champion Iron, Lowers Price Target to C$6.5

Benchmark analyst Reuben Garner reiterates Beacon Roofing Supply (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BECN#NASDAQ">BECN</a>) with a Buy and maintains $140 price target.

Comments

Implanet

Notizie

Ultime notizie per Implanet (OTC:IMPZY) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO